Global Pelvic Organ Prolapse Devices Market Size By Device (Vaginal Pessary, Vaginal Mesh), By Application (Surgical Devices, Non-Surgical Devices), By End-User (Hospitals, Ambulatory Surgical Centers), By Geographic Scope And Forecast

Pelvic Organ Prolapse Devices Market Size And Forecast

Pelvic Organ Prolapse Devices Market size was valued at USD 185.36 Million in 2022 and is projected to reach USD 405.12 Million By 2030 , growing at a CAGR of 4.12% from 2023 to 2030. The increasing global geriatric population and rising prevalence of POP in the aging female population are expected to drive the Pelvic Organ Prolapse Devices Market over the predicted years. The Global Pelvic Organ Prolapse Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Pelvic Organ Prolapse Devices Market Definition

Pelvic organ prolapse is a condition that occurs after the supporting tissues and muscles become weak or loose in the pelvic region. Though the disease is treatable, pelvic organ prolapse devices are meant to provide support to the pelvic organs including the bladder, uterus, small intestine, and part of the vagina.

The prolapse of the bladder is known as a cystocele. While prolapse of the small bowel is known as enterocele. If there's a prolapse of the rectum, it is known as a rectocele. The devices for pelvic organ prolapse are vaginal pessary and vaginal mesh. They are used in applications including Surgical Devices and Non-Surgical Devices. End-users of pelvic organ prolapse devices are Hospitals, Ambulatory Surgical Centers, and Others.

Global Pelvic Organ Prolapse Devices Market Overview

The increasing global geriatric population and rising prevalence of POP in the aging female population are expected to drive the Pelvic Organ Prolapse Devices Market over the predicted years. Besides this, the healthcare expenditure growth has witnessed exponential growth over the past couple of decades and it is expected to show the similar trend over the forecasted period. This will further complement the adoption of pelvic organ prolapse devices over the upcoming years. As per the data published by the World Health Organization, Pelvic organ prolapse is one of the most common in disease found across the women aged 60 to 69. Around 37% of the POP patients are between 60-70 years of age and more than half of the patients are more than 80 years of age.

In addition to this, technical advancements and ngoing research and developments in pelvic organ prolapse repair treatments and the growing awareness about women's health expect a boost to the market in the coming years.The ongoing investments and frequent need for the respective treatments will create substantial opportunities over the forecasted period. However, there are certain restraints and challenges faced which can hinder market growth. Factors such as lack of scientific efficacy & safety, higher costs involved in surgeries, and complex regulatory norms and standards will restrict the demand to some extent.

Global Pelvic Organ Prolapse Devices Market: Segmentation Analysis

The Global Pelvic Organ Prolapse Devices Market is Segmented on the basis of Device, Application, End-User, and Geography.

Pelvic Organ Prolapse Devices Market, By Device

• Vaginal Pessary
• Vaginal Mesh

Based on Device, the market is bifurcated into Vaginal Pessary and Vaginal Mesh. The Vaginal Pessary segment is expected to hold the largest market share. The factors can be attributed to a higher preference for vaginal pessary as vaginal mesh causes bleeding which are one of the most commonly found instances wherein the pelvic organ prolapse devices are generally used.

Pelvic Organ Prolapse Devices Market, By Application

• Surgical Devices
• Non-Surgical Devices

Based on Application, the market is bifurcated into Surgical Devices and Non-Surgical Devices. Surgical Devices are predicted to hold the most significant CAGR in the forecasted period as surgical devices are more effective than non-surgical devices in the treatment of pelvic organ prolapse. On the other hand, non surgical devices will also significant share considering the varying needs in line with the symptoms and medication instances.

Pelvic Organ Prolapse Devices Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Others

Based on End-User, the market is bifurcated into Hospitals, Ambulatory Surgical Centers, and Others. Hospitals are anticipated to hold the largest market share. These factors can be credited to the higher rate of surgeries, growing treatment instances in the hospitals and lack of device applications in other clinics and ambulatory surgical centers. However, the ambulatory surgical centers will grow at the significant rate considering the rising awareness and ease of access.

Pelvic Organ Prolapse Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
• On the basis of regional analysis, the GlobalPelvic Organ Prolapse Devices Market is classified into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America led the Global Pelvic Organ Prolapse Devices Market in terms of growth, accounting for a sizable market share. The region is technologically advanced, and it was an early adoption of advanced healthcare technologies. Besides this, the strengthened healthcare infrastructure will further complement the market growth.

Key Players

• The "Global Pelvic Organ Prolapse Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Johnson & Johnson Services, Inc., Coloplast Pty Ltd, Boston Scientific Corporation, CooperSurgical, Inc., Dr. Arabin GmbH & Co. KG, Integra LifeSciences, , Utah Medical Products, Inc., Tic Med, Cleo, Shenzhen XFT Medical Limited, Sunmedix Co, Ltd., Verity Medical Ltd, Neomedic, and Medtronic among others.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In March 2020, the pelvic organ prolapse devices manufacturers, Fotofinder Zsystems Inc. has rebranded automated total body mapping systems as total body dermoscopy, allowing for immediate evaluation of dermoscopic structures of oles on full body photos.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
• Active, Cutting Edge, Emerging, and Innovators.
• Market Attractiveness
• The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Pelvic Organ Prolapse Devices market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. The porter's five forces model can be used to assess the competitive landscape in global Pelvic Organ Prolapse Devices market, gauge the attractiveness of a certain sector, and assess investment possibilities.